In Europe, more than 3 million people are diagnosed with cancer each year. But recent advances in cancer treatment have offered new hope to those battling the disease.
Cancer biomarkers are molecules that are usually produced by cancer cells which can be detected in bodily fluids or tissues.
A distinct lack of awareness means that blood cancers are not being treated as a priority health challenge at the EU level or by many national governments.
ETUI Senior Researcher Aida Ponce talks to ETUC Confederal Secretary Esther Lynch about the priorities and gender challenges that employees face at their workplace.
In an interview with EURACTIV at the September European Obesity Forum in Brussels, EPODE methodology founder Dr. Jean-Michel Borys stressed the importance of the implication of decision-makers at all levels in childhood obesity prevention.
2,1 billion people, or nearly 30% of the world’s population, are either obese or overweight, one in five of them being children. As costs for obesity related diseases (diabetes, cancer, cardiovascular conditions etc.) continue to rise, already representing 1% to 3% of the total health expenditure in most countries, governments and decision-makers should focus their efforts on prevention.
The 2014 Euro Diabetes Index was presented at the 50th Congress of the European Association for the Study of Diabetes (EASD) in Vienna. It is a tool for awareness and advocacy at national and European level to empower patients and physicians through comparing and reviewing health care provision and policies regarding diabetes in all member states plus Norway and Switzerland.
José Ramón González Juanatey, president of the Spanish Society of Cardiology, has called on the EU to regulate the salt and fat content of foods, “as they clearly promote obesity, diabetes and cardiovascular diseases”. “The EU and also national governments must have the responsibility to regulate”, Juanatey said.
